Nano Cap Stocks
Discover investment opportunities in Nano Cap Stocks using our Smart AI Filter.
AI is processing your request...
AI is analyzing your request
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Nano Cap Stocks using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Nano Cap Stocks using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Nano Cap Stocks using our Smart AI Filter.
6 stocks found for "Nano Cap Stocks"
Security name | Expected returns | Sharpe Ratio | Beta | Volatility | P/E Ratio | Dividend Yield |
---|---|---|---|---|---|---|
0.87 Risk measure | ±100.0% Price volatility | -3.9 Valuation | 0.00% Annual yield | |||
1.05 Risk measure | ±100.0% Price volatility | — Valuation | 0.00% Annual yield | |||
1.36 Risk measure | ±100.0% Price volatility | -0.1 Valuation | 0.00% Annual yield | |||
1.13 Risk measure | ±100.0% Price volatility | -0.1 Valuation | 0.00% Annual yield | |||
0.90 Risk measure | ±81.9% Price volatility | 0.0 Valuation | 0.00% Annual yield | |||
0.51 Risk measure | ±100.0% Price volatility | -1.9 Valuation | 0.00% Annual yield |
This search uses our Smart AI Filter to identify stocks matching your criteria. Results are ranked by relevance and include key financial metrics to help you make informed investment decisions.
Get personalized stock recommendations, save custom screens, and access premium filters. All our screening tools are free—signing up gives you more personalized results and the ability to save your research.
Compliance disclosure:
The securities listed on this website have not paid to be included in the results. The inclusion of any securities in the results shown does not imply any relationship with PortfolioPilot. The order of the results is ranked based on the Sharpe Ratio, which is a measure of risk-adjusted return. Please note that these listings are not recommendations or financial advice. Past performance is not indicative of future results.
Cyclacel Pharmaceuticals, Inc. CYCC stock is trading higher on Tuesday, with a session volume of 21.9 million compared to the average volume of 206.9K, as per data from Benzinga Pro.
Read moreU.S. stock futures were mixed this morning, with the Dow futures falling around 0.1% on Tuesday.
Read moreAccelerate Diagnostics (AXDX) came out with a quarterly loss of $0.59 per share versus the Zacks Consensus Estimate of a loss of $0.47. This compares to loss of $0.92 per share a year ago.
Read moreGenprex (GNPX) gains 9.5% after expanding clinical study sites in the United States for the early to mid-stage study of lead candidate, Reqorsa, to treat lung cancer patients.
Read moreThe mean of analysts' price targets for Helius Medical Technologies, Inc. (HSDT) points to a 1249.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Read moreAfter surging 400% yesterday, Aethlon Medical, Inc. (NASDAQ: AEMD) shares are trading lower after the company announced a 1.38-million share registered direct offering priced at $9 per share. The gross proceeds to Aethlon, before deducting placement agent fees and other offering expenses, are expected to be approximately $12.425 million.
Read more